The latest research from Fore Pharma, Europe Obesity Market and Competitive Landscape – 2020, provides comprehensive insights into Obesity pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Obesity market size and drug sales. It also provides insights into Obesity epidemiology and late stage pipeline.
This research covers the following – Obesity treatment options, Obesity late stage clinical trials pipeline, Obesity prevalence by countries, Obesity market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).
Research Scope:
– Countries: Germany, France, Italy, Spain, UK, Europe
– Obesity pipeline: Find out drugs in clinical trials for Obesity by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Obesity epidemiology: Find out number of patients diagnosed (prevalence) with Obesity by countries
– Obesity drugs: Identify key drugs marketed and prescribed for Obesity by countries, including trade name, molecule name, and company
– Obesity drugs sales: Find out the sales value for Obesity drugs by countries
– Obesity market valuations: Find out the market size for Obesity drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Obesity drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Obesity drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Obesity market
– Develop in-depth knowledge of competition and markets
– Analyze Obesity drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Obesity market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Obesity Treatment Options
2. Obesity Pipeline Insights
2.1. Obesity Phase 3 Clinical Trials
2.2. Obesity Phase 2 Clinical Trials
2.3. Obesity Phase 1 Clinical Trials
3. Obesity Epidemiology Analysis by Countries
4. Germany Obesity Market Insights
4.1. Marketed Drugs for Obesity in Germany
4.2. Germany Obesity Market Size & Forecast
4.3. Germany Obesity Drugs Sales Forecast
4.4. Germany Obesity Market Share Analysis
5. France Obesity Market Insights
5.1. Marketed Drugs for Obesity in France
5.2. France Obesity Market Size & Forecast
5.3. France Obesity Product Sales Forecast
5.4. France Obesity Market Share Analysis
6. Italy Obesity Market Insights
6.1. Marketed Drugs for Obesity in Italy
6.2. Italy Obesity Market Size & Forecast
6.3. Italy Obesity Product Sales Forecast
6.4. Italy Obesity Market Share Analysis
7. Spain Obesity Market Insights
7.1. Marketed Drugs for Obesity in Spain
7.2. Spain Obesity Market Size & Forecast
7.3. Spain Obesity Product Sales Forecast
7.4. Spain Obesity Market Share Analysis
8. UK Obesity Market Insights
8.1. Marketed Drugs for Obesity in UK
8.2. UK Obesity Market Size & Forecast
8.3. UK Obesity Product Sales Forecast
8.4. UK Obesity Market Share Analysis
9. Europe Obesity Market Insights
9.1. Europe Obesity Market Size & Forecast
9.2. Europe Obesity Product Sales Forecast
9.3. Europe Obesity Market Share Analysis
10. Research Methodology
List of Tables
1: Obesity Phase 3 Clinical Trials, Global, 2020
2: Obesity Phase 2 Clinical Trials, Global, 2020
3: Obesity Phase 1 Clinical Trials, Global, 2020
4: Obesity Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Obesity in Germany, 2019
6: Germany Obesity Market Size & Forecast ($mn), 2016 – 2025
7: Germany Obesity Product Sales ($mn), 2016 – 2025
8: Germany Obesity Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Obesity in France, 2019
10: France Obesity Market Size & Forecast ($mn), 2016 – 2025
11: France Obesity Product Sales ($mn), 2016 – 2025
12: France Obesity Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Obesity in Italy, 2019
14: Italy Obesity Market Size & Forecast ($mn), 2016 – 2025
15: Italy Obesity Product Sales ($mn), 2016 – 2025
16: Italy Obesity Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Obesity in Spain, 2019
18: Spain Obesity Market Size & Forecast ($mn), 2016 – 2025
19: Spain Obesity Product Sales ($mn), 2016 – 2025
20: Spain Obesity Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Obesity in UK, 2019
22: UK Obesity Market Size & Forecast ($mn), 2016 – 2025
23: UK Obesity Product Sales ($mn), 2016 – 2025
24: UK Obesity Market Events and Trends, 2016 – 2025
25: Europe Obesity Market Size & Forecast ($mn), 2016 – 2025
26: Europe Obesity Product Sales ($mn), 2016 – 2025
List of Figures
1: Obesity Pipeline by Phase (%), Global, 2020
2: Obesity Prevalence by Countries, 2016 – 2025
3: Germany Obesity Market Size ($mn), 2016 – 2025
4: Germany Obesity Product Sales ($mn), 2016 – 2025
5: Germany Obesity Market Share by Drugs (%), 2019
6: Germany Obesity Market – Future Market Share (%), 2025
7: France Obesity Market Size ($mn), 2016 – 2025
8: France Obesity Product Sales ($mn), 2016 – 2025
9: France Obesity Market Share by Drugs (%), 2019
10: France Obesity Market – Future Market Share (%), 2025
11: Italy Obesity Market Size ($mn), 2016 – 2025
12: Italy Obesity Product Sales ($mn), 2016 – 2025
13: Italy Obesity Market Share by Drugs (%), 2019
14: Italy Obesity Market – Future Market Share (%), 2025
15: Spain Obesity Market Size ($mn), 2016 – 2025
16: Spain Obesity Product Sales ($mn), 2016 – 2025
17: Spain Obesity Market Share by Drugs (%), 2019
18: Spain Obesity Market – Future Market Share (%), 2025
19: UK Obesity Market Size ($mn), 2016 – 2025
20: UK Obesity Product Sales ($mn), 2016 – 2025
21: UK Obesity Market Share by Drugs (%), 2019
22: UK Obesity Market – Future Market Share (%), 2025
23: Europe Obesity Market Size ($mn), 2016 – 2025
24: Europe Obesity Product Sales ($mn), 2016 – 2025
25: Europe Obesity Market Share by Drugs (%), 2019
26: Europe Obesity Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.